Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring

Alzheimers Dement (Amst)

2352-8729

2352-8729

Therapeutic Area

Behavioural Neuroscience, Biochemistry, Computational Biology, Diagnostic Imaging, Diagnostics/Diagnostic Testing, Epidemiology, Etiology, Genetics, Genomics, Geriatrics, Health Economics/Outcomes Research, Health Services Research, Molecular Biology, Neuro Biology, Neurodegenerative Disorders, Neurology, Neuropsychiatry, Neuropsychology, Pathology, Pharmacology, Physiology, Political Science, Proteomics, Psychiatry, Research, Sociology

Bio Chemists, Computational Biologists, Diagnosticians, Epidemiologists, Etiologists, Geneticists, Geriatricians, Health Professionals, Health Service Researchers, Molecular Biologists, Neuro Biologists, Neurologists, Neuropsychiatrists, Neuropsychologists, Pathologists, Pharmacologists, Physiologists, Political Scientists, Psychiatrists, Researchers, Scientists, Scientists - Research/Biomedical Aging, Sociologists

Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring (DADM) is an open access journal concentrating on the discovery, development, and validation of assays, instruments, and technologies with the potential to facilitate accurate detection of dementia in its various forms and stages. Of particular interest are promising dementia biomarkers. The mission of Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring is to bridge the knowledge gaps across a wide range of bench-to-bedside investigation. Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring publishes the results of studies in: behavior, biochemistry, genetics, molecular biology, pharmacology, physiology, protein chemistry, neurology, neuropathology, psychiatry, geriatrics, neuropsychology, epidemiology, sociology, health services research, health economics, political science and public policy. Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring emphasizes interdisciplinary investigations and integrative/translational articles related to: etiology, risk factors, early detection, disease modifying interventions, prevention of dementia, and applications of new technologies in health services. The ultimate objective is to create a novel forum for: rapid communication of new findings, ideas, or perspectives; disseminating knowledge, across the spectrum of basic to clinical studies, necessary for optimal translation of research findings into practical applications/interventions; integrating knowledge across disciplines; increasing knowledge in diverse disciplines to promote early detection/diagnosis and/or interventions; formulating new theories and/or strategies for the rigorous testing of theories or their predictions; identifying promising new directions of research; and providing the scientific impetus for new initiatives or public policies concerning research on prevention and new models of health services. Aims to provide insight on important problems that emerge from clinical care or from rigorous broad-based clinical research in Alzheimer's Disease and Related Dementias (ADRD) and to provide multidisciplinary scientific integration of data in regard to diagnosis and longitudinal disease monitoring of ADRD. Scope: Research on the methodological advances and conceptual challenges encountered in the diagnosis, prognosis and disease management of ADRD; Research on the discovery, development, and validation of tools and biomarkers for diagnosis and disease monitoring and Inclusive of research on the early and accurate identification of individuals at elevated risk for various memory disorders, both asymptomatic and those with cognitive complaints.

Alzheimer's Association (AA)

John Wiley & Sons, Inc. - NJ

Impact Factor JCR Categories/Rank Electronic Circulation Submission to Acceptance Acceptance to Online Publication Rejection Rate Frequency Author Submission Guidelines